Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park
SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the…
Don’t Dangle Your Participle: More Than 8,000 English Teachers Convene for National Conference in Baltimore Nov. 21-24
BALTIMORE, Nov. 20, 2019 /PRNewswire/ -- More than 8,000 English teachers from across the country will gather in Baltimore, Nov. 21–24 for the 109th Annual Convention of the National Council of…
FDA approves first treatment for inherited rare disease
SILVER SPRING, Md., Nov. 20, 2019 /PRNewswire/ -- Today, the Food and Drug Administration granted approval to Givlaari (givosiran) for the treatment of adult patients with acute hepatic porphyria, a genetic…